235 related articles for article (PubMed ID: 33442460)
1. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report.
Yokoo H; Takahashi H; Hagiwara M; Iwata H; Imai K; Saito Y; Matsuno N; Furukawa H
World J Hepatol; 2020 Dec; 12(12):1349-1357. PubMed ID: 33442460
[TBL] [Abstract][Full Text] [Related]
2. Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy.
Ohya Y; Hayashida S; Tsuji A; Kuramoto K; Shibata H; Setoyama H; Hayashi H; Kuriwaki K; Sasaki M; Iizaka M; Nakahara O; Inomata Y
Surg Case Rep; 2020 Dec; 6(1):318. PubMed ID: 33301055
[TBL] [Abstract][Full Text] [Related]
3. A case of conversion hepatectomy for huge ruptured hepatocellular carcinoma after transarterial embolization and lenvatinib therapy.
Naganuma A; Suzuki Y; Hoshino T; Yasuoka H; Tamura Y; Naruse H; Tanaka H; Hirai K; Sakamoto I; Ogawa T; Hatanaka T; Kakizaki S
Clin J Gastroenterol; 2022 Feb; 15(1):177-184. PubMed ID: 34811701
[TBL] [Abstract][Full Text] [Related]
4. Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report.
Takahashi K; Kim J; Takahashi A; Hashimoto S; Doi M; Furuya K; Hashimoto R; Owada Y; Ogawa K; Ohara Y; Akashi Y; Hisakura K; Enomoto T; Shimomura O; Noguchi M; Oda T
World J Hepatol; 2021 Mar; 13(3):384-392. PubMed ID: 33815680
[TBL] [Abstract][Full Text] [Related]
5. Conversion surgery after lenvatinib treatment for multiple lung metastases from hepatocellular carcinoma.
Sano S; Asahi Y; Kamiyama T; Kakisaka T; Orimo T; Nagatsu A; Aiyama T; Kazui K; Shomura H; Ueki S; Sakamoto Y; Shirakawa C; Kamachi H; Sugino H; Mitsuhashi T; Taketomi A
Int Cancer Conf J; 2023 Jan; 12(1):7-13. PubMed ID: 36605836
[TBL] [Abstract][Full Text] [Related]
6. Downstaging of Recurrent Advanced Hepatocellular Carcinoma After Lenvatinib Treatment: Opportunities or Pitfalls? A Case Report.
Liu Z; Fu Z; Li G; Lin D
Onco Targets Ther; 2020; 13():10267-10273. PubMed ID: 33116607
[TBL] [Abstract][Full Text] [Related]
7. A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma.
Shiozaki H; Furukawa K; Haruki K; Matsumoto M; Uwagawa T; Onda S; Yamahata Y; Ishizaki S; Abe K; Fujioka S; Nakaseko Y; Okamoto T; Ikegami T
Anticancer Res; 2023 Apr; 43(4):1761-1766. PubMed ID: 36974796
[TBL] [Abstract][Full Text] [Related]
8. The Outcome of Conversion Liver Resection Surgery by Lenvatinib Treatment: A Single Center Experience.
Hidaka M; Hara T; Soyama A; Sasaki R; Matsushima H; Tanaka T; Hamada T; Imamura H; Adachi T; Kanetaka K; Miyaaki H; Okano S; Eguchi S
Anticancer Res; 2022 Jun; 42(6):3049-3054. PubMed ID: 35641262
[TBL] [Abstract][Full Text] [Related]
9. Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report.
Chen Z; Chen Z; Fan W; Zou Y; Zhang Y; Shi N; Jin H
World J Surg Oncol; 2023 Jan; 21(1):29. PubMed ID: 36721173
[TBL] [Abstract][Full Text] [Related]
10. Recurrent hepatogastric fistula during lenvatinib therapy for advanced hepatocellular carcinoma managed by over-the-scope clip closure: a case report.
Miwa T; Kochi T; Watanabe K; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Katsumura N; Shimizu M
J Rural Med; 2021 Apr; 16(2):102-110. PubMed ID: 33833836
[No Abstract] [Full Text] [Related]
11. Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report.
Shiraishi J; Itoh S; Tomino T; Yoshiya S; Nagao Y; Morita K; Kayashima H; Harada N; Ichiki Y; Yoshizumi T
J Surg Case Rep; 2023 Aug; 2023(8):rjad485. PubMed ID: 37645700
[TBL] [Abstract][Full Text] [Related]
12. [Combined Modality Therapy for Giant Hepatocellular Carcinoma and Multiple Lung Metastases-A Case Study].
Hasegawa H; Kawakubo E; Kitagawa D; Kishihara F; Funahashi S; Kitamura M
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2251-2253. PubMed ID: 33468924
[TBL] [Abstract][Full Text] [Related]
13. Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study.
Yi Y; Sun BY; Weng JL; Zhou C; Zhou CH; Cai MH; Zhang JY; Gao H; Sun J; Zhou J; Fan J; Ren N; Qiu SJ
Front Oncol; 2022; 12():1046584. PubMed ID: 36505772
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control Study.
Chen YY; Chen CL; Lin CC; Wang CC; Liu YW; Li WF; Chen YH
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572811
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases.
Morsica G; Bertoni C; Hasson H; Messina E; Uberti Foppa C
Front Oncol; 2023; 13():1242741. PubMed ID: 38115904
[TBL] [Abstract][Full Text] [Related]
16. Lenvatinib-induced tumor lysis syndrome in a patient with advanced hepatocellular carcinoma: a case report.
Shimizu Y; Sunagozaka H; Yamagata K; Hirai H; Miura M; Yonemoto Y; Naito Y; Hasatani K; Yoshikawa J; Aoyagi H; Kaneko S
Clin J Gastroenterol; 2021 Apr; 14(2):645-649. PubMed ID: 33389590
[TBL] [Abstract][Full Text] [Related]
17. Hypothyroidism and hypopituitarism as immune-related adverse events due to lenvatinib plus pembrolizumab therapy in the immediate postoperative period after laparoscopic hepatectomy for liver metastases from gastric cancer: a case report.
Sasaki K; Kobayashi S; Kudo M; Sugimoto M; Takahashi S; Nakamura Y; Kawazoe A; Shitara K; Kinoshita T; Gotohda N
Surg Case Rep; 2021 Dec; 7(1):267. PubMed ID: 34928436
[TBL] [Abstract][Full Text] [Related]
18. Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.
Chen K; Luo CP; Ge DX; Wang KL; Luo Q; Li YZ; You XM; Xiang BD; Li LQ; Ma L; Zhong JH
Front Oncol; 2022; 12():946693. PubMed ID: 36276151
[TBL] [Abstract][Full Text] [Related]
19. The successful posterior sectionectomy accompanied with caudate lobectomy for hepatocellular carcinoma located in segment 1 after LEN-TACE: a case report.
Nanashima A; Hamada T; Hiyoshi M; Imamura N; Tsuchimochi Y; Shimizu I; Nagata K; Kawakami H
Clin J Gastroenterol; 2024 Feb; ():. PubMed ID: 38353862
[TBL] [Abstract][Full Text] [Related]
20. Recurrent hepatocellular carcinoma with tumor thrombus in right atrium - report of a successful liver resection with tumor thrombectomy using total hepatic vascular exclusion without concomitant cardiopulmonary bypass.
Shivathirthan N; Shimoda M; Kosuge T; Kato M; Kijima H; Sawada T; Kubota K
Hepatogastroenterology; 2012 May; 59(115):872-4. PubMed ID: 22469735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]